http://rdf.ncbi.nlm.nih.gov/pubchem/reference/24901821

Outgoing Links

Predicate Object
contentType Case Reports|Journal Article|Research Support, Non-U.S. Gov't
endingPage 254
issn 0169-5002
issueIdentifier 2
pageRange 253-254
publicationName Lung cancer (Amsterdam, Netherlands)
startingPage 253
bibliographicCitation Ahn HK, Han B, Lee SJ, Lim T, Sun JM, Ahn JS, Ahn MJ, Park K. ALK inhibitor crizotinib combined with intrathecal methotrexate treatment for non-small cell lung cancer with leptomeningeal carcinomatosis. Lung Cancer. 2012 May;76(2):253–4. doi: 10.1016/j.lungcan.2012.02.003. PMID: 22385925.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2b83fcd61aaa4ef397b3c05c6c1eb5b0
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bdde301f6d4dd9313e261b488686fdf7
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_560e4cdea526c99c647c7e28d78f494b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e5d7628ce6ef1755eaccb5416dea6acf
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_23a64e98b9c553b221a9efd4bc68e300
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cbd50b0e4452e949131b0f13ee453da1
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_66702ee5c97af7c9b9881732adfb199b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1e22f047db2a1626fb14d80b7e434496
date 201205
identifier https://pubmed.ncbi.nlm.nih.gov/22385925
https://doi.org/10.1016/j.lungcan.2012.02.003
isPartOf https://portal.issn.org/resource/ISSN/0169-5002
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/8534
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title ALK inhibitor crizotinib combined with intrathecal methotrexate treatment for non-small cell lung cancer with leptomeningeal carcinomatosis
discusses http://id.nlm.nih.gov/mesh/M0493054
http://id.nlm.nih.gov/mesh/M0328256
http://id.nlm.nih.gov/mesh/M0553416
http://id.nlm.nih.gov/mesh/M0018226
http://id.nlm.nih.gov/mesh/M0018233
http://id.nlm.nih.gov/mesh/M0228330
http://id.nlm.nih.gov/mesh/M0457532
http://id.nlm.nih.gov/mesh/M0013595
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D020794Q000037
http://id.nlm.nih.gov/mesh/D008175Q000188
http://id.nlm.nih.gov/mesh/D000971Q000627
http://id.nlm.nih.gov/mesh/D055756Q000188
http://id.nlm.nih.gov/mesh/D002289Q000188
hasSubjectTerm http://id.nlm.nih.gov/mesh/D047428Q000008
http://id.nlm.nih.gov/mesh/D011720Q000008
http://id.nlm.nih.gov/mesh/D008727Q000008
http://id.nlm.nih.gov/mesh/D008175Q000201
http://id.nlm.nih.gov/mesh/D000077548
http://id.nlm.nih.gov/mesh/D008175Q000378
http://id.nlm.nih.gov/mesh/D000368
http://id.nlm.nih.gov/mesh/D002289Q000378
http://id.nlm.nih.gov/mesh/D011725Q000008
http://id.nlm.nih.gov/mesh/D020794Q000378
http://id.nlm.nih.gov/mesh/D055756Q000378
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D002289Q000201
http://id.nlm.nih.gov/mesh/D000077547
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7168
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11137
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11626560
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID126941

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID376229599
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID53790123
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID243164928
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID160644611
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID238

Total number of triples: 66.